BRIEF-AstraZeneca, Bristol resubmit dapagliflozin in U.S.

July 25 Thu Jul 25, 2013 7:42am EDT

July 25 (Reuters) - AstraZeneca PLC : * Astrazeneca Plc and Bristol-Myers Squibb Co say resubmit

dapagliflozin new drug application in the U.S.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.